[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pediatric-safety\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pediatric-safety":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":5},"100657499","pediatric-acceptability-evaluation-of-a-cosmetic-product-100657499",false,"NCT07839104","Pediatric Acceptability Evaluation of a Cosmetic Product","Clinical Evaluation of Pediatric Acceptability of a Cosmetic Product","Inclusion Criteria:\n\n* Male and female participants aged from 7 days to 14 years.\n* Participants whose parent(s) and\u002For legal guardian(s) agree to comply with all study procedures and attend the study site on the scheduled dates and times for assessments.\n* Parent(s) and\u002For legal guardian(s) able to understand the study requirements and provide written informed consent by signing the Informed Consent Form (ICF) prior to the performance of any study-specific procedures.\n* When applicable, participants able to understand and provide assent by signing the Assent Form, according to their age, maturity, and level of understanding.\n* Inclusion of at least one newborn participant.\n\nExclusion Criteria:\n\n* Use of anti-inflammatory, immunosuppressive, or antihistamine medications within 3 weeks prior to screening.\n* Skin conditions or marks in the test area that may interfere with the evaluation of potential skin reactions, including vascular malformations, scars, excessive hair growth, multiple nevi, or sunburn.\n* History of atopy or allergic reactions to cosmetic products.\n* Active skin diseases and\u002For lesions (localized or widespread) in the assessment area.\n* Immunosuppression due to medication use or active disease.\n* Uncontrolled endocrine disorders.\n* Known history of or suspected intolerance to products of the same category.\n* Intense sun exposure within 15 days prior to assessment.\n* Aesthetic or dermatological treatments within 4 weeks prior to assessment.\n* Any other condition that, in the investigator's opinion, may reasonably justify exclusion from the study",true,"ALL","7 Days","14 Years",{"count":21,"type":22},33,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this clinical trial is to evaluate the dermatological safety and acceptability of a cosmetic product in healthy pediatric participants. The main questions it aims to answer are:\n\n* Does the investigational product demonstrate pediatric acceptability under normal conditions of use?\n* Does the investigational product present a low risk of skin irritation in the pediatric population?\n* Are any discomfort sensations reported during product use?\n\nParticipants will:\n\n* Apply the investigational product to the face and body twice daily for 21 days.\n* Undergo clinical evaluations to assess skin tolerability and identify any signs of irritation or adverse reactions.\n* Be monitored for potential discomfort sensations throughout the study period. The study will enroll 33 healthy male and female participants aged from 7 days to 14 years. This is a single-center, single-blind clinical trial designed to evaluate the safety of the investigational product through clinical assessments under normal conditions of use.",[28],"Pediatric Safety",[30,28,31,32,33,34,35,36,37],"Pediatric Acceptability","Dermatological Safety","Skin Tolerability","Cosmetic Product","Infants","Children","Skin Irritation","Pediatric Skin Care","RECRUITING","2026-09-23",{"date":41,"type":42},"2026-09-24","ACTUAL",{"date":44,"type":22},"2026-10-21",{"date":46,"type":22},"2026-12-07",{"name":48,"class":49},"Brainfarma Industria Química e Farmacêutica S\u002FA","INDUSTRY"]